Technology

Latest News


Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.

Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

CME Content


Patient's whose complete hospital treatment was captured by an electronic health record were up to 30% less likely to experience in-hospital adverse events.

What we're reading, January 19, 2016: the Obama administration is looking to make it easier for patients to access their medical records; a clinical trial has left 1 brain dead and 4 hospitalized; and hospitals are experimenting with mobile technologies to track patient health at home.

What we're reading, January 18, 2016: even if there is no drug price control legislation, pharmaceutical companies may bow to political pressure; study finds physician-led hospitals perform better; and Twitter can be used to obtain the patient perspective on medical errors.

What we're reading, January 14, 2016: President Obama proposes extending financial assistance for new states expanding Medicaid eligibility; Hillary Clinton goes hard after Bernie Sanders on single-payer healthcare; and health information exchanges reduce repeated imaging procedures.

Neglecting patient and caregiver preferences hamstrings the development of medical technologies and engaging these stakeholders is vital, said John Bridges, PhD, associate professor of the Johns Hopkins Bloomberg School of Public Health.

What we're reading, December 9, 2015: the federal government recovered $200 million from state's whose health insurance exchanges faltered; drug cocktails are responsible for majority of drug overdose deaths in Massachusetts; and healthcare organizations are not confident in their ability to share patient data while protecting patient privacy.

The challenge with data in oncology is making sense of it and connecting it in a way that clinicians can make insights that inform the care they provide patients in real time, said Robert J. Green, MD, vice president of clinical strategy and senior medical director at Flatiron Health.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo